Summary
Considerable disagreement exists regarding the levels of immunoreactive glucose dependent insulinotropic polypeptide in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Glucose dependent insulinotropic polypeptide levels were therefore studied during oral glucose and mixed meal tolerance tests in normal subjects (n=31) and newly presenting previously untreated patients with Type 2 diabetes mellitus (n=68). The tests were performed in random order after overnight fasts and blood samples were taken at 30 min intervals for 4 h. During the oral glucose tolerance test plasma glucose dependent insulinotropic polypeptide levels increased in the normal subjects from a fasting value of 20±3 pmol/l to a peak of 68±5 pmol/l at 30 min and in the Type 2 diabetic patients from a similar fasting level of 27±3 pmol/l to a higher peak value of 104±6 pmol/l at 30 min (p<0.001). Glucose dependent insulinotropic polypeptide levels were significantly higher in the diabetic patients compared with the normal subjects from 30–90 min (p<0.01–0.001) following oral glucose. During the meal tolerance test glucose dependent insulinotropic polypeptide levels increased in the normal subjects from a pre-prandial value of 22±4 pmol/l to a peak of 93±6 pmol/l at 90 min and in the Type 2 diabetic patients from a similar basal level of 25±2 pmol/l to a higher peak of 133±7 pmol/l at 60 min. Glucose dependent insulinotropic polypeptide concentrations were significantly higher in Type 2 diabetic patients compared with the normal subjects at 30 min (p<0.001), 60 min (p<0.01) and from 210–240 min (p<0.05) during the meal tolerance test. The groups were subdivided on the basis of degree of obesity and glucose dependent insulinotropic polypeptide concentrations were still higher in the diabetic subgroups compared with the normal subjects matched for weight. Type 2 diabetes mellitus is associated with an exaggerated glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals which is independent of any effect of obesity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Brown JCL, Pedersen RA (1970) A multiparameter study on the action of preparations containing cholecystokinin — pancreozymin. Scand J Gastroenterol 5: 537–541
Dupre J, Ross SA, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 37: 826–828
Brown JC, Dryburgh JR, Ross SA, Dupre J (1975) Identification and actions of gastric inhibitory polypeptide. Recent Prog Horm Res 31: 487–532
Crockett SE, Mazzaferri EL, Cataland S (1976) Gastric inhibitory polypeptide (Glucose dependent insulinotropic polypeptide) in maturity onset diabetes mellitus. Diabetes 25: 931–935
Ross SA, Brown JC, Dupre J (1977) Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus. Diabetes 26: 525–529
May JM, Williams RH (1978) The effect of endogenous gastric inhibitory polypeptide on glucose induced insulin secretion in mild diabetes. Diabetes 27: 849–855
Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L (1983) Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type 1 (insulin-dependent) diabetes. J Clin Endocrinol Metab 56: 1306–1312
Salera M, Giacomoni P, Pironi L, Cormia G, Capella M, Marini A, Benfenate F, Miglioli M, Barbara L (1982) Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus and obesity. J Clin Endocrinol Metab 55: 329–336
Service FJ, Rizza RA, Westland RE, Hall LD, Gerich JE, Go VLW (1984) Gastric inhibitory polypeptide in obesity and diabetes mellitus. J Clin Endocrinol Metab 58: 1133–1140
Sarson DL, Bryant MG, Bloom SR (1980) A radioimmunoassay of gastric inhibitory polypeptide in human plasma. J Endocrinol 85: 487–496
Cleastor JGM, Gourlay RH (1975) Release of immunoreactive gastric inhibitory polypeptide (immunoreactive-glucose dependent insulinotropic polypeptide) by oral ingestion of food substances. Am J Surg 130: 128–135
Jorde R, Burhol PG, Schultz TB (1983) Fasting and post-prandial plasma glucose dependent insulinotropic polypeptide values in man measured with seven different antisera. Regul Pep 7: 87–94
Krarup T, Holst JJ (1984) The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pep 9: 35–46
Krarup T, Holst JJ, Larsen KL (1985) Responses and molecular heterogeneity of immunoreactive-glucose dependent insulinotropic polypeptide after intraduodenal glucose and fat. Am J Physiol 249: E195–200
Moody AJ, Thim L, Valverde I (1984) The isolation and sequencing of human gastric inhibitory polypeptide (glucose dependent insulinotropic polypeptide) FEBS Letters 172: 142–148
Falko JM, Crockett SE, Cataland S, Mazzaferri EL (1975) Gastric inhibitory polypeptide (glucose dependent insulinotropic polypeptide) stimulated by fat ingestion in man. J Clin Endocrinol Metab 41: 260–265
Thomas FB, Mazzaferri EL, Crockett SE, Makhjian HS, Gruemer HD, Cataland S (1976) Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology 70: 523–527
Jones IR, Owens DR, Luzio S, Davies CJ, Hayes TM (1983) The relationship between carbohydrate tolerance and differential hepatic extraction of insulin in response to serial glucose and meal tolerance tests in normal subjects. Diabetologia 25: 168 (Abstract)
Krarup T (1988) Immunoreactive gastric inhibitory polypeptide. Endocrine Reviews 9: 122–134
Moody AJ, Damm Jorgensen K, Thim L (1981) Structure function relationships in porcine glucose dependent insulinotropic polypeptide. Diabetologia 21: 306 (Abstract)
Heding LG (1972) Determination of total serum insulin (immunoreactive insulin) in insulin treated diabetic patients. Diabetologia 8: 260–266
Heding LG (1975) Radioimmunological determination of human C peptide in serum. Diabetologia 11: 541–548
Sarson DL, Kopelman PG, Besterman HS, Pilkington TRE, Bloom SR (1983) Disparity between glucose dependent insulinotropic polypeptide and insulin responses in obese man. Diabetologia 25: 386–391
Hampton SM, Kwasowski P, Tan K, Morgan LM, Marks V (1983) Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats. Diabetologia 24: 278–281
Creutzfeldt W, Ebert R, Willms B, Frerichs H, Brown JC (1978) Gastric inhibitory polypeptide (glucose dependent insulinotropic polypeptide) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia 14: 15–24
Creutzfeldt W (1979) The incretin concept today. Diabetologia 16: 75–78
Jones IR, Owens DR, Luzio S, Hayes TM (1986) Gastric inhibitory polypeptide (glucose dependent insulinotropic polypeptide) concentrations and the hyperinsulinaemia of obesity. Diabetic Medicine 4: 367 (Abstract)
Dryburgh JR, Hampton SM, Morgan LM, Marks V (1980) C peptide induced inhibition of glucose dependent insulinotropic polypeptide release. Regul Pep 1: 28 (Abstract)
Larrimer JN, Mazzaferri EL, Cataland S, Mekhjian HS (1978) Effect of atropine on glucose stimulated gastric inhibitory polypeptide. Diabetes 27: 638–642
Baumert JE, Cataland S, Tetirick CE, Pace WG, Mazzaferri EL (1978) Effect of atropine on meal stimulated gastrin and gastric inhibitory polypeptide (glucose dependent insulinotropic polypeptide) release. J Clin Endocrinol Metal 31: 473–476
Nauck M, Stockmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in Type 2 (non-insulin dependent) diabetes. Diabetologia 29: 46–52
Jones IR, Owens DR, Moody AJ, Luzio SD, Morris T, Hayes TM (1987) The effects of glucose dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion. Diabetologia 30: 707–712
Paul AA, Southgate DAT (1985) The composition of foods 4th edn. McCance and Widdowson, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, I.R., Owens, D.R., Luzio, S. et al. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32, 668–677 (1989). https://doi.org/10.1007/BF00274255
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274255